HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bernardo Rapoport Selected Research

rolapitant

6/2017Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy.
1/2017Rolapitant for the prevention of delayed nausea and vomiting over initial and repeat courses of emetogenic chemotherapy.
1/2017Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy.
4/2016Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy.
11/2015Study of rolapitant, a novel, long-acting, NK-1 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV) due to highly emetogenic chemotherapy (HEC).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bernardo Rapoport Research Topics

Disease

15Vomiting
06/2017 - 02/2005
13Nausea
06/2017 - 02/2005
5Neoplasms (Cancer)
12/2021 - 12/2003
2Neutropenia
06/2019 - 06/2013
2Breast Neoplasms (Breast Cancer)
07/2013 - 01/2003
2Colorectal Neoplasms (Colorectal Cancer)
12/2011 - 09/2008
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2019
1Dizziness (Lightheadedness)
11/2015
1Fatigue
11/2015
1Headache (Headaches)
11/2015
1Constipation
11/2015
1Hand-Foot Syndrome
08/2015
1Febrile Neutropenia
06/2013
1Infections
06/2013
1Drug-Related Side Effects and Adverse Reactions
09/2008
1Anemia
12/2003
1Hematologic Neoplasms (Hematological Malignancy)
12/2003
1Cardiotoxicity
01/2003

Drug/Important Bio-Agent (IBA)

7AntiemeticsIBA
01/2017 - 02/2005
5rolapitantIBA
06/2017 - 11/2015
5Dexamethasone (Maxidex)FDA LinkGeneric
01/2017 - 02/2005
35-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
01/2017 - 12/2011
2Neurokinin-1 Receptor AntagonistsIBA
06/2017 - 04/2016
2Aprepitant (Emend)FDA Link
06/2017 - 01/2017
2Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
01/2017 - 11/2015
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2017 - 01/2003
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 01/2003
2ErbB Receptors (EGF Receptor)IBA
08/2015 - 09/2008
2Cetuximab (Erbitux)FDA Link
12/2011 - 09/2008
1Immune Checkpoint InhibitorsIBA
12/2021
1netupitantIBA
06/2017
1fosaprepitantFDA Link
06/2017
1Palonosetron (Aloxi)FDA Link
06/2017
1Capsules (Microcapsules)IBA
06/2017
1SuspensionsIBA
06/2017
1TabletsIBA
06/2017
1Olanzapine (Zyprexa)FDA Link
01/2017
1Antineoplastic Agents (Antineoplastics)IBA
01/2017
1Metoclopramide (Reglan)FDA LinkGeneric
01/2017
1Pharmaceutical PreparationsIBA
01/2017
1EmeticsIBA
01/2017
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2017
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2017
1Dopamine AntagonistsIBA
01/2017
1human ERBB2 proteinIBA
07/2013
1Capecitabine (Xeloda)FDA Link
07/2013
1Sorafenib (BAY 43-9006)FDA Link
07/2013
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
06/2013
1Leucovorin (Folinic Acid)FDA Link
12/2011
1Fluorouracil (Carac)FDA LinkGeneric
12/2011
1Irinotecan (Camptosar)FDA LinkGeneric
12/2011
1Serotonin 5-HT3 Receptor AntagonistsIBA
12/2011
1Panitumumab (Vectibix)FDA Link
09/2008
1Monoclonal AntibodiesIBA
09/2008
1Epoetin Alfa (Epogen)FDA Link
12/2003
1PlatinumIBA
12/2003
1Paclitaxel (Taxol)FDA LinkGeneric
01/2003
1AnthracyclinesIBA
01/2003

Therapy/Procedure

17Drug Therapy (Chemotherapy)
06/2019 - 12/2003
5Therapeutics
06/2019 - 12/2003
1Intravenous Infusions
06/2017